This effect might be independent of the induction of IFN-λ3 expression reported previously.4,5 Our findings may partly reveal the unknown mechanism by which patients with CHB who receive TDF have a better prognosis and lower risk of developing HCC than the patients with CHB who receive ETV. This evidence concerns the gene IFNL3 and hepatocellular carcinoma.